Plus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics' First Quarter 2024 Results Conference Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.04 | 4,902 | 5,717 | 2024-05-08 | Filing | ||
$2.04 | 12,255 | 12,425 | 2024-05-08 | Filing | ||
$2.04 | 12,255 | 36,421 | 2024-05-08 | Filing | ||
$2.04 | 9,804 | 21,497 | 2024-05-08 | Filing | ||
$2.04 | 4,902 | 4,903 | 2024-05-08 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.96 | 2,068 | Officer, Director | 170 | 2023-11-20 | Filing | |
$0.31 | 1,500 | Director | 8,500 | 2022-12-30 | Filing | |
$0.34 | 473,831 | Large Shareholder | 4,543,086 | 2018-02-14 | Filing | |
$0.31 | 101,710 | Large Shareholder | 5,016,917 | 2018-02-13 | Filing | |
$0.31 | 185,272 | Large Shareholder | 5,118,627 | 2018-02-12 | Filing |